511 related articles for article (PubMed ID: 24558067)
21. Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma?
Turrini O; Ewald J; Barbier L; Mokart D; Blache JL; Delpero JR
Ann Surg; 2013 Apr; 257(4):726-30. PubMed ID: 22968078
[TBL] [Abstract][Full Text] [Related]
22. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
[TBL] [Abstract][Full Text] [Related]
23. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head.
Leach SD; Lee JE; Charnsangavej C; Cleary KR; Lowy AM; Fenoglio CJ; Pisters PW; Evans DB
Br J Surg; 1998 May; 85(5):611-7. PubMed ID: 9635805
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
[TBL] [Abstract][Full Text] [Related]
25. Planned versus unplanned portal vein resections during pancreaticoduodenectomy for adenocarcinoma.
Kim PT; Wei AC; Atenafu EG; Cavallucci D; Cleary SP; Moulton CA; Greig PD; Gallinger S; Serra S; McGilvray ID
Br J Surg; 2013 Sep; 100(10):1349-56. PubMed ID: 23939847
[TBL] [Abstract][Full Text] [Related]
26. Histopathological tumor invasion of the mesenterico-portal vein is characterized by aggressive biology and stromal fibroblast activation.
Lapshyn H; Bolm L; Kohler I; Werner M; Billmann FG; Bausch D; Hopt UT; Makowiec F; Wittel UA; Keck T; Bronsert P; Wellner UF
HPB (Oxford); 2017 Jan; 19(1):67-74. PubMed ID: 27825542
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of cryopreserved homologous veins for venous reconstruction in pancreatoduodenectomy.
Yamamoto M; Akamatsu N; Aoki T; Sakamoto Y; Tamura S; Hasegawa K; Kokudo N
Surgery; 2017 Feb; 161(2):385-393. PubMed ID: 27726914
[TBL] [Abstract][Full Text] [Related]
28. Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy.
Zhao X; Li LX; Fan H; Kou JT; Li XL; Lang R; He Q
J Int Med Res; 2016 Dec; 44(6):1339-1348. PubMed ID: 28322103
[TBL] [Abstract][Full Text] [Related]
29. Venous thrombosis following pancreaticoduodenectomy with venous resection.
Mohammed S; Mendez-Reyes JE; McElhany A; Gonzales-Luna D; Van Buren G; Bland DS; Villafane-Ferriol N; Pierzynski JA; West CA; Silberfein EJ; Fisher WE
J Surg Res; 2018 Aug; 228():271-280. PubMed ID: 29907222
[TBL] [Abstract][Full Text] [Related]
30. The importance of invasion and resection of superior mesenteric and portal veins in adenocarcinoma of the pancreas.
Aktekin A; Küçük M; Odabaşi M; Muftuoglu T; Gürleyik G; Özkara S; Aker F; Saglam A
Hepatogastroenterology; 2013; 60(125):1194-8. PubMed ID: 23803382
[TBL] [Abstract][Full Text] [Related]
31. Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis.
Chu CK; Farnell MB; Nguyen JH; Stauffer JA; Kooby DA; Sclabas GM; Sarmiento JM
J Am Coll Surg; 2010 Sep; 211(3):316-24. PubMed ID: 20800187
[TBL] [Abstract][Full Text] [Related]
32. Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk?
Marsoner K; Langeder R; Csengeri D; Sodeck G; Mischinger HJ; Kornprat P
Wien Klin Wochenschr; 2016 Aug; 128(15-16):566-72. PubMed ID: 27363995
[TBL] [Abstract][Full Text] [Related]
33. Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma.
Shimada K; Sano T; Sakamoto Y; Kosuge T
Ann Surg Oncol; 2006 Dec; 13(12):1569-78. PubMed ID: 17009145
[TBL] [Abstract][Full Text] [Related]
34. Postoperative Outcomes of Tangential
Lapshyn H; Schulte T; Petruch N; Petrova E; Honselmann K; Deichmann S; Braun R; Kulemann B; Hoeppner J; Rades D; Keck T; Wellner UF; Bausch D; Bolm L
Anticancer Res; 2021 Oct; 41(10):5123-5130. PubMed ID: 34593463
[TBL] [Abstract][Full Text] [Related]
35. Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection.
Mierke F; Hempel S; Distler M; Aust DE; Saeger HD; Weitz J; Welsch T
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):730-736. PubMed ID: 27554501
[TBL] [Abstract][Full Text] [Related]
36. Pancreatoduodenectomy with portal vein resection is feasible and potentially beneficial for elderly patients with pancreatic cancer.
Kanda M; Fujii T; Suenaga M; Takami H; Inokawa Y; Yamada S; Kobayashi D; Tanaka C; Sugimoto H; Nomoto S; Fujiwara M; Kodera Y
Pancreas; 2014 Aug; 43(6):951-8. PubMed ID: 24717827
[TBL] [Abstract][Full Text] [Related]
37. Long-term results of pancreaticoduodenectomy with superior mesenteric and portal vein resection for ductal adenocarcinoma in the head of the pancreas.
Landi F; Dopazo C; Sapisochin G; Beisani M; Blanco L; Caralt M; Balsells J; Charco R
Cir Esp; 2015 Oct; 93(8):522-9. PubMed ID: 25981612
[TBL] [Abstract][Full Text] [Related]
38. Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma.
Murakami Y; Satoi S; Motoi F; Sho M; Kawai M; Matsumoto I; Honda G;
Br J Surg; 2015 Jun; 102(7):837-46. PubMed ID: 25877050
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
[TBL] [Abstract][Full Text] [Related]
40. Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis.
Yu XZ; Li J; Fu DL; Di Y; Yang F; Hao SJ; Jin C
Eur J Surg Oncol; 2014 Apr; 40(4):371-8. PubMed ID: 24560302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
